FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/07/044166 [Registered on: 20/07/2022] Trial Registered Prospectively
Last Modified On: 08/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective observational 
Study Design  Single Arm Study 
Public Title of Study   Role of lung ultrasound in diagnosing and management of respiratory distress syndrome in 34 weeks neonates 
Scientific Title of Study   Diagnostic utility of lung ultrasound in predicting the surfactant therapy for preterm infants 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pari Singh 
Designation  DM neonatology Resident 
Affiliation  Bharati Vidyapeeth medical College, Pune 
Address  Department of Neonatology, Division of ICU, Room NICU, Bharati Hospital, B. V. D. U., Pune
Dhankawadi, Katraj
Pune
MAHARASHTRA
411043
India 
Phone  8178646479  
Fax    
Email  parisingh19@icloud.com  
 
Details of Contact Person
Scientific Query
 
Name  Pradeep Suryawanshi 
Designation  Professor and Head 
Affiliation  Bharati Vidyapeeth medical College, Pune 
Address  Department of Neonatology, Division of ICU, Room NICU, Bharati Hospital, B. V. D. U., Pune
Dhankawadi, Katraj
Pune
MAHARASHTRA
411043
India 
Phone  8178646479  
Fax    
Email  drpradeepsuryawanshi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pari Singh 
Designation  DM neonatology Resident 
Affiliation  Bharati Vidyapeeth medical College, Pune 
Address  Department of Neonatology, Division of ICU, Room NICU, Bharati Hospital, B. V. D. U., Pune
Dhankawadi, Katraj
Pune
MAHARASHTRA
411043
India 
Phone  8178646479  
Fax    
Email  parisingh19@icloud.com  
 
Source of Monetary or Material Support  
Department of Neonatology, Division of ICU, Room NICU, Bharati Hospital, B. V. D. U., Pune 
 
Primary Sponsor  
Name  Bharati Vidyapeeth Medical College 
Address  Department of Neonatology, Division of ICU, Room NICU, Bharati Hospital, B. V. D. U., Pune 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pari Singh  Bharati Vidyapeeth Medical College  Department of Neonatology, Division of ICU, Room NICU, Bharati Hospital, B. V. D. U., Pune
Pune
MAHARASHTRA 
8178646479

parisingh19@icloud.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethical Committee B. V. D. U. Medical College, Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J99||Respiratory disorders in diseasesclassified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  1.00 Day(s)
Gender  Both 
Details  < 34 weeks neonates admitted to NICU within 6 hours of life with respiratory distress 
 
ExclusionCriteria 
Details  1. >34 weeks
2. No respiratory distress
3. Admission beyond 6 hours of life to NICU 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine the diagnostic accuracy of lung ultrasound score in predicting the need for first dose of surfactant therapy in preterm infants (34weeks) with respiratory distress.
To determine the diagnostic accuracy of lung USG score in predicting the need for second dose of surfactant therapy in preterm infants(34 weeks) with respiratory distress, if indicated clinically 
6 hours 
 
Secondary Outcome  
Outcome  TimePoints 
To determine the change in LUS score after six hours of surfactant therapy  six hours after surfactant first dose 
To determine the distribution of LUS score with corresponding oxygen saturation to fraction oxygenation ratio (S/F)  admission 
To determine the distribution of LUS score with corresponding arterial/alveolar oxygenation ratio (PaO2/PAO2)  at admission 
To determine the distribution of LUS score with corresponding chest x-ray (CXR)-based classification of RDS as mild, moderate and severe RDS  admission 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/07/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This  study is being taken up to predict the the diagnostic accuracy of neonatal lung USG score as a lone marker for evaluating the need for surfactant administration in preterm infants with respiratory distress. We hypothesize that since LUS score reflects lung aeration, it will correlate with requirement of surfactant in preterm babies with respiratory distress. In future, it can prove to be an accurate and early predictor for the need for surfactant therapy in this cohort, thus, allowing timely treatment and as low as reasonably achievable (ALARA) radiation exposure.


 
Close